Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model.
Journal Information
Full Title: Front Cardiovasc Med
Abbreviation: Front Cardiovasc Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Cardiac & Cardiovascular Systems
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest S086 is Salubris’ developing product, and Salubris is the patent owner. JS, YX, WXu, and WXi were employed by Shenzhen Salubris Pharmaceutical Co., Ltd. FD, MT, DD, YR and XF were employed by WuXi AppTec (Shanghai) Co., Ltd."
"The author(s) declare financial support was received for the research, authorship, and/or publication of this article.Shenzhen Science and Technology Program (Grant No. KQTD20200820151701004)"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025